SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-121827
Filing Date
2024-11-06
Accepted
2024-11-06 08:00:10
Documents
12
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nams-20241106.htm   iXBRL 8-K 51290
2 EX-99.1 nams-ex99_1.htm EX-99.1 453449
  Complete submission text file 0000950170-24-121827.txt   685730

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20241106.xsd EX-101.SCH 55021
14 EXTRACTED XBRL INSTANCE DOCUMENT nams-20241106_htm.xml XML 6452
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 241429283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)